{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T14:00:18Z","timestamp":1792159218645,"version":"4.4.0"},"reference-count":228,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,3,21]],"date-time":"2023-03-21T00:00:00Z","timestamp":1679356800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100007302","name":"Beijing University of Chemical Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007302","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2020YFA0712102"],"award-info":[{"award-number":["2020YFA0712102"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["20SWAQK22"],"award-info":[{"award-number":["20SWAQK22"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["BWS21J025"],"award-info":[{"award-number":["BWS21J025"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012226","name":"Fundamental Research Funds for the Central Universities","doi-asserted-by":"publisher","award":["BUCTZY2022"],"award-info":[{"award-number":["BUCTZY2022"]}],"id":[{"id":"10.13039\/501100012226","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013804","name":"Fundamental Research Funds for the Central Universities","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013804","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82151224"],"award-info":[{"award-number":["82151224"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82202492"],"award-info":[{"award-number":["82202492"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Advanced Research"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1016\/j.jare.2023.03.007","type":"journal-article","created":{"date-parts":[[2023,3,30]],"date-time":"2023-03-30T04:56:20Z","timestamp":1680152180000},"page":"137-156","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":49,"special_numbering":"C","title":["Advances in anti-EV-A71 drug development research"],"prefix":"10.1016","volume":"56","author":[{"given":"Shuqi","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zehan","family":"Pang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huahao","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yigang","family":"Tong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.jare.2023.03.007_b0005","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1093\/infdis\/129.3.304","article-title":"An apparently new enterovirus isolated from patients with disease of the central nervous system","volume":"129","author":"Schmidt","year":"1974","journal-title":"J Infect Dis"},{"issue":"10","key":"10.1016\/j.jare.2023.03.007_b0010","first-page":"1889","article-title":"MR imaging findings of enteroviral encephaloymelitis: an outbreak in Taiwan","volume":"20","author":"Shen","year":"1999","journal-title":"AJNR Am J Neuroradiol"},{"issue":"1","key":"10.1016\/j.jare.2023.03.007_b0015","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/1423-0127-21-14","article-title":"Recent developments in antiviral agents against enterovirus 71 infection","volume":"21","author":"Tan","year":"2014","journal-title":"J Biomed Sci"},{"issue":"13","key":"10.1016\/j.jare.2023.03.007_b0020","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1056\/NEJM199909233411301","article-title":"An epidemic of enterovirus 71 infection in Taiwan. Taiwan Enterovirus Epidemic Working Group","volume":"341","author":"Ho","year":"1999","journal-title":"N Engl J Med"},{"issue":"9","key":"10.1016\/j.jare.2023.03.007_b0025","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1056\/NEJMoa1304923","article-title":"Efficacy, safety, and immunogenicity of an enterovirus 71 vaccine in China","volume":"370","author":"Zhu","year":"2014","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.jare.2023.03.007_b0030","doi-asserted-by":"crossref","first-page":"e2895","DOI":"10.1371\/journal.pntd.0002895","article-title":"A novel universal neutralizing monoclonal antibody against enterovirus 71 that targets the highly conserved \u201cknob\u201d region of VP3 protein","volume":"8","author":"Kiener","year":"2014","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.jare.2023.03.007_b0035","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.intimp.2017.11.042","article-title":"Andrographolide sulfonate reduces mortality in Enterovirus 71 infected mice by modulating immunity","volume":"55","author":"Li","year":"2018","journal-title":"Int Immunopharmacol"},{"issue":"6","key":"10.1016\/j.jare.2023.03.007_b0040","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1038\/s41579-018-0005-4","article-title":"The life cycle of non-polio enteroviruses and how to target it","volume":"16","author":"Baggen","year":"2018","journal-title":"Nat Rev Microbiol"},{"issue":"2","key":"10.1016\/j.jare.2023.03.007_b0045","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.coviro.2012.02.009","article-title":"Recent advances in the molecular epidemiology and control of human enterovirus 71 infection","volume":"2","author":"McMinn","year":"2012","journal-title":"Curr Opin Virol"},{"key":"10.1016\/j.jare.2023.03.007_b0050","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.ejmech.2019.06.008","article-title":"Back to the future: advances in development of broad-spectrum capsid-binding inhibitors of enteroviruses","volume":"178","author":"Egorova","year":"2019","journal-title":"Eur J Med Chem"},{"issue":"9","key":"10.1016\/j.jare.2023.03.007_b0055","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1007\/s13238-014-0087-3","article-title":"Molecular mechanism of SCARB2-mediated attachment and uncoating of EV71","volume":"5","author":"Dang","year":"2014","journal-title":"Protein Cell"},{"issue":"4","key":"10.1016\/j.jare.2023.03.007_b0060","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1016\/j.apsb.2021.08.017","article-title":"Enterovirus A71 antivirals: past, present, and future","volume":"12","author":"Wang","year":"2022","journal-title":"Acta Pharm Sin B"},{"issue":"5","key":"10.1016\/j.jare.2023.03.007_b0065","first-page":"426","article-title":"Molecular epidemiology and evolution of human enterovirus 71 and hand, foot and mouth disease","volume":"37","author":"Liu","year":"2015","journal-title":"Yi Chuan"},{"issue":"2","key":"10.1016\/j.jare.2023.03.007_b0070","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1007\/s11262-021-01830-3","article-title":"Natural intertypic and intratypic recombinants of enterovirus 71 from mainland China during 2009\u20132018: a complete genome analysis","volume":"57","author":"Xu","year":"2021","journal-title":"Virus Genes"},{"issue":"7","key":"10.1016\/j.jare.2023.03.007_b0075","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1038\/nm.1992","article-title":"Scavenger receptor B2 is a cellular receptor for enterovirus 71","volume":"15","author":"Yamayoshi","year":"2009","journal-title":"Nat Med"},{"issue":"7","key":"10.1016\/j.jare.2023.03.007_b0080","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1038\/nm.1961","article-title":"Human P-selectin glycoprotein ligand-1 is a functional receptor for enterovirus 71","volume":"15","author":"Nishimura","year":"2009","journal-title":"Nat Med"},{"issue":"22","key":"10.1016\/j.jare.2023.03.007_b0085","doi-asserted-by":"crossref","first-page":"11809","DOI":"10.1128\/JVI.00297-11","article-title":"Annexin II binds to capsid protein VP1 of enterovirus 71 and enhances viral infectivity","volume":"85","author":"Yang","year":"2011","journal-title":"J Virol"},{"issue":"1","key":"10.1016\/j.jare.2023.03.007_b0090","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1128\/JVI.02226-12","article-title":"Enterovirus 71 uses cell surface heparan sulfate glycosaminoglycan as an attachment receptor","volume":"87","author":"Tan","year":"2013","journal-title":"J Virol"},{"key":"10.1016\/j.jare.2023.03.007_b0095","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1186\/1743-422X-6-141","article-title":"Sialylated glycans as receptor and inhibitor of enterovirus 71 infection to DLD-1 intestinal cells","volume":"6","author":"Yang","year":"2009","journal-title":"Virol J"},{"issue":"7","key":"10.1016\/j.jare.2023.03.007_b0100","first-page":"e53","article-title":"Receptors for enterovirus 71","volume":"3","author":"Yamayoshi","year":"2014","journal-title":"Emerg Microbes Infect"},{"issue":"1","key":"10.1016\/j.jare.2023.03.007_b0105","doi-asserted-by":"crossref","first-page":"e30507","DOI":"10.1371\/journal.pone.0030507","article-title":"Human SCARB2-mediated entry and endocytosis of EV71","volume":"7","author":"Lin","year":"2012","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.jare.2023.03.007_b0110","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1074\/jbc.M110.168468","article-title":"The essential role of clathrin-mediated endocytosis in the infectious entry of human enterovirus 71","volume":"286","author":"Hussain","year":"2011","journal-title":"J Biol Chem"},{"issue":"1","key":"10.1016\/j.jare.2023.03.007_b0115","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s12929-020-0615-9","article-title":"Cellular receptors for enterovirus A71","volume":"27","author":"Kobayashi","year":"2020","journal-title":"J Biomed Sci"},{"issue":"11","key":"10.1016\/j.jare.2023.03.007_b0120","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1016\/S1473-3099(10)70194-8","article-title":"Virology, epidemiology, pathogenesis, and control of enterovirus 71","volume":"10","author":"Solomon","year":"2010","journal-title":"Lancet Infect Dis"},{"issue":"4","key":"10.1016\/j.jare.2023.03.007_b0125","doi-asserted-by":"crossref","first-page":"313","DOI":"10.3109\/1040841X.2011.580723","article-title":"The virology and developments toward control of human enterovirus 71","volume":"37","author":"Yi","year":"2011","journal-title":"Crit Rev Microbiol"},{"key":"10.1016\/j.jare.2023.03.007_b0130","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.antiviral.2016.08.009","article-title":"Inhibition of enterovirus VP4 myristoylation is a potential antiviral strategy for hand, foot and mouth disease","volume":"133","author":"Tan","year":"2016","journal-title":"Antiviral Res"},{"issue":"1","key":"10.1016\/j.jare.2023.03.007_b0135","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1093\/nar\/gkn901","article-title":"Far upstream element binding protein 2 interacts with enterovirus 71 internal ribosomal entry site and negatively regulates viral translation","volume":"37","author":"Lin","year":"2009","journal-title":"Nucleic Acids Res"},{"issue":"8","key":"10.1016\/j.jare.2023.03.007_b0140","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1007\/s13238-017-0405-7","article-title":"The binding of a monoclonal antibody to the apical region of SCARB2 blocks EV71 infection","volume":"8","author":"Zhang","year":"2017","journal-title":"Protein Cell"},{"key":"10.1016\/j.jare.2023.03.007_b0145","doi-asserted-by":"crossref","unstructured":"Zhu L, Xu K, Wang N, et al. Neutralization mechanisms of two highly potent antibodies against human enterovirus 71. mBio. 2018;9(4).","DOI":"10.1128\/mBio.01013-18"},{"issue":"5","key":"10.1016\/j.jare.2023.03.007_b0150","doi-asserted-by":"crossref","first-page":"e34589","DOI":"10.1371\/journal.pone.0034589","article-title":"Inhibition of enterovirus 71 (EV-71) infections by a novel antiviral peptide derived from EV-71 capsid protein VP1","volume":"7","author":"Tan","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.jare.2023.03.007_b0155","doi-asserted-by":"crossref","DOI":"10.1016\/j.meegid.2020.104210","article-title":"Acarbose, as a potential drug, effectively blocked the dynamic metastasis of EV71 from the intestine to the whole body","volume":"81","author":"Feng","year":"2020","journal-title":"Infect Genet Evol"},{"issue":"8","key":"10.1016\/j.jare.2023.03.007_b0160","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1080\/21505594.2015.1094605","article-title":"Antibodies to P-selectin glycoprotein ligand-1 block dendritic cell-mediated enterovirus 71 transmission and prevent virus-induced cells death","volume":"6","author":"Ren","year":"2015","journal-title":"Virulence"},{"issue":"10","key":"10.1016\/j.jare.2023.03.007_b0165","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1021\/acsinfecdis.9b00070","article-title":"Efficient blocking of enterovirus 71 infection by heparan sulfate analogues acting as decoy receptors","volume":"5","author":"Earley","year":"2019","journal-title":"ACS Infect Dis"},{"issue":"1","key":"10.1016\/j.jare.2023.03.007_b0170","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.virusres.2012.06.025","article-title":"In vitro evaluation of the antiviral activity of heparan sulfate mimetic compounds against Enterovirus 71","volume":"169","author":"Pourianfar","year":"2012","journal-title":"Virus Res"},{"issue":"2","key":"10.1016\/j.jare.2023.03.007_b0175","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1159\/000355872","article-title":"Global impact of heparin on gene expression profiles in neural cells infected by enterovirus 71","volume":"57","author":"Pourianfar","year":"2014","journal-title":"Intervirology"},{"issue":"23","key":"10.1016\/j.jare.2023.03.007_b0180","doi-asserted-by":"crossref","first-page":"12084","DOI":"10.1128\/JVI.02189-15","article-title":"Single neutralizing monoclonal antibodies targeting the VP1 GH loop of enterovirus 71 inhibit both virus attachment and internalization during viral entry","volume":"89","author":"Ku","year":"2015","journal-title":"J Virol"},{"issue":"8","key":"10.1016\/j.jare.2023.03.007_b0185","doi-asserted-by":"crossref","first-page":"4527","DOI":"10.1128\/JVI.03498-14","article-title":"Cell surface nucleolin facilitates enterovirus 71 binding and infection","volume":"89","author":"Su","year":"2015","journal-title":"J Virol"},{"issue":"14","key":"10.1016\/j.jare.2023.03.007_b0190","doi-asserted-by":"crossref","first-page":"5463","DOI":"10.1073\/pnas.1222379110","article-title":"Structure of human enterovirus 71 in complex with a capsid-binding inhibitor","volume":"110","author":"Plevka","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"10.1016\/j.jare.2023.03.007_b0195","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1016\/j.jmii.2022.01.004","article-title":"The role of conserved arginine and proline residues in enterovirus VP1 protein","volume":"55","author":"Huang","year":"2022","journal-title":"J Microbiol Immunol Infect"},{"issue":"2","key":"10.1016\/j.jare.2023.03.007_b0200","doi-asserted-by":"crossref","DOI":"10.3390\/v14020364","article-title":"Conserved residues adjacent to \u00df-barrel and loop intersection among enterovirus VP1 affect viral replication: potential target for anti-enteroviral development","volume":"14","author":"Huang","year":"2022","journal-title":"Viruses"},{"issue":"3","key":"10.1016\/j.jare.2023.03.007_b0205","first-page":"257","article-title":"Ballesteros F.[Pleconaril, a new aniviral drug with activity against picornavirus]","volume":"13","author":"Reina","year":"2000","journal-title":"Rev Esp Quimioter"},{"issue":"2","key":"10.1016\/j.jare.2023.03.007_b0210","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1086\/318452","article-title":"Treatment of potentially life-threatening enterovirus infections with pleconaril","volume":"32","author":"Rotbart","year":"2001","journal-title":"Clin Infect Dis"},{"issue":"4","key":"10.1016\/j.jare.2023.03.007_b0215","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1007\/s00705-011-1222-6","article-title":"In vitro and in vivo evaluation of ribavirin and pleconaril antiviral activity against enterovirus 71 infection","volume":"157","author":"Zhang","year":"2012","journal-title":"Arch Virol"},{"key":"10.1016\/j.jare.2023.03.007_b0220","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.antiviral.2016.04.003","article-title":"Susceptibilities of enterovirus D68, enterovirus 71, and rhinovirus 87 strains to various antiviral compounds","volume":"131","author":"Smee","year":"2016","journal-title":"Antiviral Res"},{"issue":"8","key":"10.1016\/j.jare.2023.03.007_b0225","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1021\/jm010536a","article-title":"Design, synthesis, and structure-activity relationship of pyridyl imidazolidinones: a novel class of potent and selective human enterovirus 71 inhibitors","volume":"45","author":"Shia","year":"2002","journal-title":"J Med Chem"},{"issue":"20","key":"10.1016\/j.jare.2023.03.007_b0230","doi-asserted-by":"crossref","first-page":"5051","DOI":"10.1016\/j.bmcl.2004.07.084","article-title":"Synthesis and antienteroviral activity of a series of novel, oxime ether-containing pyridyl imidazolidinones","volume":"14","author":"Chern","year":"2004","journal-title":"Bioorg Med Chem Lett"},{"issue":"3","key":"10.1016\/j.jare.2023.03.007_b0235","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1007\/s11373-007-9228-5","article-title":"Antiviral activity of pyridyl imidazolidinones against enterovirus 71 variants","volume":"15","author":"Chen","year":"2008","journal-title":"J Biomed Sci"},{"issue":"10","key":"10.1016\/j.jare.2023.03.007_b0240","doi-asserted-by":"crossref","first-page":"3522","DOI":"10.1021\/jm050033v","article-title":"Design, synthesis, and antipicornavirus activity of 1-[5-(4-arylphenoxy)alkyl]-3-pyridin-4-ylimidazolidin-2-one derivatives","volume":"48","author":"Chang","year":"2005","journal-title":"J Med Chem"},{"issue":"3","key":"10.1016\/j.jare.2023.03.007_b0245","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1038\/nsmb.2769","article-title":"More-powerful virus inhibitors from structure-based analysis of HEV71 capsid-binding molecules","volume":"21","author":"De Colibus","year":"2014","journal-title":"Nat Struct Mol Biol"},{"issue":"3","key":"10.1016\/j.jare.2023.03.007_b0250","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1080\/03639045.2018.1562464","article-title":"The inactivation of the non-enveloped enterovirus 71 (EV71) by a novel disinfectant gel formulation for topical use","volume":"45","author":"Ma","year":"2019","journal-title":"Drug Dev Ind Pharm"},{"issue":"9","key":"10.1016\/j.jare.2023.03.007_b0255","doi-asserted-by":"crossref","first-page":"3523","DOI":"10.1128\/AAC.48.9.3523-3529.2004","article-title":"Mutation in enterovirus 71 capsid protein VP1 confers resistance to the inhibitory effects of pyridyl imidazolidinone","volume":"48","author":"Shih","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"issue":"3","key":"10.1016\/j.jare.2023.03.007_b0260","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1021\/acs.jmedchem.9b01414","article-title":"Design, synthesis, and evaluation of novel enterovirus 71 inhibitors as therapeutic drug leads for the treatment of human hand, foot, and mouth disease","volume":"63","author":"Zhang","year":"2020","journal-title":"J Med Chem"},{"issue":"21","key":"10.1016\/j.jare.2023.03.007_b0265","doi-asserted-by":"crossref","first-page":"14792","DOI":"10.1021\/acs.jmedchem.2c01311","article-title":"Discovery and optimization of quinoline analogues as novel potent antivirals against enterovirus D68","volume":"65","author":"Li","year":"2022","journal-title":"J Med Chem"},{"issue":"1","key":"10.1016\/j.jare.2023.03.007_b0270","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1021\/acs.jmedchem.9b01737","article-title":"Scaffold simplification strategy leads to a novel generation of dual human immunodeficiency virus and enterovirus-A71 entry inhibitors","volume":"63","author":"Mart\u00ednez-Gualda","year":"2020","journal-title":"J Med Chem"},{"issue":"14","key":"10.1016\/j.jare.2023.03.007_b0275","doi-asserted-by":"crossref","first-page":"10027","DOI":"10.1021\/acs.jmedchem.1c00315","article-title":"Double arylation of the indole side chain of tri- and tetrapodal tryptophan derivatives renders highly potent HIV-1 and EV-A71 entry inhibitors\u2020","volume":"64","author":"Mart\u00ed-Mar\u00ed","year":"2021","journal-title":"J Med Chem"},{"key":"10.1016\/j.jare.2023.03.007_b0280","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.antiviral.2019.06.006","article-title":"Modifications in the branched arms of a class of dual inhibitors of HIV and EV71 replication expand their antiviral spectrum","volume":"168","author":"Mart\u00ednez-Gualda","year":"2019","journal-title":"Antiviral Res"},{"issue":"41","key":"10.1016\/j.jare.2023.03.007_b0285","doi-asserted-by":"crossref","first-page":"10700","DOI":"10.1002\/chem.202101098","article-title":"Multivalent tryptophan- and tyrosine-containing[60]fullerene hexa-adducts as dual HIV and enterovirus A71 entry inhibitors","volume":"27","author":"Ruiz-Santaquiteria","year":"2021","journal-title":"Chemistry"},{"key":"10.1016\/j.jare.2023.03.007_b0290","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.antiviral.2013.12.008","article-title":"Suramin inhibits EV71 infection","volume":"103","author":"Wang","year":"2014","journal-title":"Antiviral Res"},{"issue":"Pt 10","key":"10.1016\/j.jare.2023.03.007_b0295","doi-asserted-by":"crossref","first-page":"2518","DOI":"10.1099\/vir.0.2008\/002915-0","article-title":"Characterization of pharmacologically active compounds that inhibit poliovirus and enterovirus 71 infectivity","volume":"89","author":"Arita","year":"2008","journal-title":"J Gen Virol"},{"issue":"2","key":"10.1016\/j.jare.2023.03.007_b0300","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1128\/JVI.02482-15","article-title":"Identification of positively charged residues in enterovirus 71 capsid protein VP1 essential for production of infectious particles","volume":"90","author":"Yuan","year":"2016","journal-title":"J Virol"},{"issue":"9","key":"10.1016\/j.jare.2023.03.007_b0305","first-page":"e62","article-title":"The approved pediatric drug suramin identified as a clinical candidate for the treatment of EV71 infection-suramin inhibits EV71 infection in vitro and in vivo","volume":"3","author":"Ren","year":"2014","journal-title":"Emerg Microbes Infect"},{"key":"10.1016\/j.jare.2023.03.007_b0310","doi-asserted-by":"crossref","first-page":"42902","DOI":"10.1038\/srep42902","article-title":"Suramin interacts with the positively charged region surrounding the 5-fold axis of the EV-A71 capsid and inhibits multiple enterovirus A","volume":"7","author":"Ren","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.jare.2023.03.007_b0315","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.3389\/fimmu.2020.01221","article-title":"The biology of lactoferrin, an iron-binding protein that can help defend against viruses and bacteria","volume":"11","author":"Kell","year":"2020","journal-title":"Front Immunol"},{"issue":"1","key":"10.1016\/j.jare.2023.03.007_b0320","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.antiviral.2005.03.005","article-title":"Lactoferrin inhibits enterovirus 71 infection by binding to VP1 protein and host cells","volume":"67","author":"Weng","year":"2005","journal-title":"Antiviral Res"},{"issue":"8","key":"10.1016\/j.jare.2023.03.007_b0325","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1086\/343809","article-title":"Lactoferrin inhibits enterovirus 71 infection of human embryonal rhabdomyosarcoma cells in vitro","volume":"186","author":"Lin","year":"2002","journal-title":"J Infect Dis"},{"issue":"4","key":"10.1016\/j.jare.2023.03.007_b0330","first-page":"395","article-title":"Effects of lactoferrin-containing formula in the prevention of enterovirus and rotavirus infection and impact on serum cytokine levels: a randomized trial","volume":"34","author":"Yen","year":"2011","journal-title":"Chang Gung Med J"},{"issue":"7","key":"10.1016\/j.jare.2023.03.007_b0335","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/j.vaccine.2007.12.013","article-title":"Recombinant porcine lactoferrin expressed in the milk of transgenic mice protects neonatal mice from a lethal challenge with enterovirus type 71","volume":"26","author":"Chen","year":"2008","journal-title":"Vaccine"},{"issue":"5","key":"10.1016\/j.jare.2023.03.007_b0340","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1046\/j.1365-2672.2003.02071.x","article-title":"The effect of bovine lactoferrin and lactoferricin B on the ability of feline calicivirus (a norovirus surrogate) and poliovirus to infect cell cultures","volume":"95","author":"McCann","year":"2003","journal-title":"J Appl Microbiol"},{"issue":"2","key":"10.1016\/j.jare.2023.03.007_b0345","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.antiviral.2005.10.006","article-title":"Bovine lactoferrin peptidic fragments involved in inhibition of Echovirus 6 in vitro infection","volume":"69","author":"Pietrantoni","year":"2006","journal-title":"Antiviral Res"},{"key":"10.1016\/j.jare.2023.03.007_b0350","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.virusres.2014.06.012","article-title":"In vitro inhibition of enterovirus 71 infection with a nickel ion\/chitosan microcomposite","volume":"190","author":"Lin","year":"2014","journal-title":"Virus Res"},{"issue":"17","key":"10.1016\/j.jare.2023.03.007_b0355","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.00061-19","article-title":"In vitro and in vivo inhibition of the infectivity of human enterovirus 71 by a sulfonated food azo dye, brilliant black BN","volume":"93","author":"Meng","year":"2019","journal-title":"J Virol"},{"issue":"1","key":"10.1016\/j.jare.2023.03.007_b0360","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsb.2020.107510","article-title":"Structure of the enterovirus D68 RNA-dependent RNA polymerase in complex with NADPH implicates an inhibitor binding site in the RNA template tunnel","volume":"211","author":"Li","year":"2020","journal-title":"J Struct Biol"},{"key":"10.1016\/j.jare.2023.03.007_b0365","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2022.926929","article-title":"Targeting emerging RNA viruses by engineered human superantibody to hepatitis C virus RNA-dependent RNA polymerase","volume":"13","author":"Glab-Ampai","year":"2022","journal-title":"Front Microbiol"},{"issue":"1","key":"10.1016\/j.jare.2023.03.007_b0370","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s12865-019-0288-x","article-title":"Monoclonal antibody against EV71 3D(pol) inhibits the polymerase activity of RdRp and virus replication","volume":"20","author":"Li","year":"2019","journal-title":"BMC Immunol"},{"issue":"6","key":"10.1016\/j.jare.2023.03.007_b0375","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1086\/527326","article-title":"Ribavirin reduces mortality in enterovirus 71-infected mice by decreasing viral replication","volume":"197","author":"Li","year":"2008","journal-title":"J Infect Dis"},{"issue":"10","key":"10.1016\/j.jare.2023.03.007_b0380","doi-asserted-by":"crossref","first-page":"5803","DOI":"10.1128\/JVI.00289-14","article-title":"Attenuation of human enterovirus 71 high-replication-fidelity variants in AG129 mice","volume":"88","author":"Meng","year":"2014","journal-title":"J Virol"},{"key":"10.1016\/j.jare.2023.03.007_b0385","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.antiviral.2015.10.011","article-title":"Synergistic antiviral activity of gemcitabine and ribavirin against enteroviruses","volume":"124","author":"Kang","year":"2015","journal-title":"Antiviral Res"},{"issue":"9","key":"10.1016\/j.jare.2023.03.007_b0390","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.00204-20","article-title":"The pyrimidine analog FNC potently inhibits the replication of multiple enteroviruses","volume":"94","author":"Xu","year":"2020","journal-title":"J Virol"},{"key":"10.1016\/j.jare.2023.03.007_b0395","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.antiviral.2014.10.009","article-title":"An adenosine nucleoside analogue NITD008 inhibits EV71 proliferation","volume":"112","author":"Shang","year":"2014","journal-title":"Antiviral Res"},{"issue":"7","key":"10.1016\/j.jare.2023.03.007_b0400","doi-asserted-by":"crossref","first-page":"2740","DOI":"10.1128\/AAC.00101-09","article-title":"Novel antiviral agent DTriP-22 targets RNA-dependent RNA polymerase of enterovirus 71","volume":"53","author":"Chen","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jare.2023.03.007_b0405","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.antiviral.2014.10.003","article-title":"BPR-3P0128 inhibits RNA-dependent RNA polymerase elongation and VPg uridylylation activities of Enterovirus 71","volume":"112","author":"Velu","year":"2014","journal-title":"Antiviral Res"},{"issue":"5","key":"10.1016\/j.jare.2023.03.007_b0410","doi-asserted-by":"crossref","first-page":"2202","DOI":"10.4049\/jimmunol.1100285","article-title":"Enterovirus 71 2C protein inhibits TNF-\u03b1-mediated activation of NF-\u03baB by suppressing I\u03baB kinase \u03b2 phosphorylation","volume":"187","author":"Zheng","year":"2011","journal-title":"J Immunol"},{"key":"10.1016\/j.jare.2023.03.007_b0415","doi-asserted-by":"crossref","first-page":"2422","DOI":"10.3389\/fmicb.2018.02422","article-title":"Innate immunity evasion by enteroviruses linked to epidemic hand-foot-mouth disease","volume":"9","author":"Jin","year":"2018","journal-title":"Front Microbiol"},{"issue":"10","key":"10.1016\/j.jare.2023.03.007_b0420","doi-asserted-by":"crossref","first-page":"5141","DOI":"10.1128\/JVI.03021-15","article-title":"2C proteins of enteroviruses suppress IKK\u03b2 phosphorylation by recruiting protein phosphatase 1","volume":"90","author":"Li","year":"2016","journal-title":"J Virol"},{"issue":"4","key":"10.1016\/j.jare.2023.03.007_b0425","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1089\/vim.2020.0173","article-title":"Enterovirus 2C protein suppresses IKK\u03b1 phosphorylation by recruiting IKK\u03b2 and IKK\u03b1 into viral inclusion bodies","volume":"34","author":"Ji","year":"2021","journal-title":"Viral Immunol"},{"issue":"4","key":"10.1016\/j.jare.2023.03.007_b0430","doi-asserted-by":"crossref","first-page":"e1602573","DOI":"10.1126\/sciadv.1602573","article-title":"Crystal structure of 2C helicase from enterovirus 71","volume":"3","author":"Guan","year":"2017","journal-title":"Sci Adv"},{"issue":"12","key":"10.1016\/j.jare.2023.03.007_b0435","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.02324-20","article-title":"Antiviral peptides targeting the helicase activity of enterovirus nonstructural protein 2C","volume":"95","author":"Fang","year":"2021","journal-title":"J Virol"},{"issue":"7","key":"10.1016\/j.jare.2023.03.007_b0440","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1021\/acsinfecdis.0c00120","article-title":"Enterovirus D68 antivirals: past, present, and future","volume":"6","author":"Hu","year":"2020","journal-title":"ACS Infect Dis"},{"issue":"11","key":"10.1016\/j.jare.2023.03.007_b0445","doi-asserted-by":"crossref","first-page":"e3000904","DOI":"10.1371\/journal.pbio.3000904","article-title":"Rational design of highly potent broad-spectrum enterovirus inhibitors targeting the nonstructural protein 2C","volume":"18","author":"Bauer","year":"2020","journal-title":"PLoS Biol"},{"issue":"8","key":"10.1016\/j.jare.2023.03.007_b0450","doi-asserted-by":"crossref","first-page":"4074","DOI":"10.1021\/acs.jmedchem.9b00115","article-title":"Discovery of quinoline analogues as potent antivirals against enterovirus D68 (EV-D68)","volume":"62","author":"Musharrafieh","year":"2019","journal-title":"J Med Chem"},{"key":"10.1016\/j.jare.2023.03.007_b0455","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2020.103981","article-title":"Development of broad-spectrum enterovirus antivirals based on quinoline scaffold","volume":"101","author":"Musharrafieh","year":"2020","journal-title":"Bioorg Chem"},{"key":"10.1016\/j.jare.2023.03.007_b0460","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112310","article-title":"Identification of dibucaine derivatives as novel potent enterovirus 2C helicase inhibitors: in vitro, in vivo, and combination therapy study","volume":"202","author":"Tang","year":"2020","journal-title":"Eur J Med Chem"},{"issue":"4","key":"10.1016\/j.jare.2023.03.007_b0465","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1021\/acs.jmedchem.7b01863","article-title":"Synthesis and structure-activity relationship (SAR) studies of novel pyrazolopyridine derivatives as inhibitors of enterovirus replication","volume":"61","author":"Xing","year":"2018","journal-title":"J Med Chem"},{"issue":"12","key":"10.1016\/j.jare.2023.03.007_b0470","doi-asserted-by":"crossref","first-page":"8755","DOI":"10.1021\/acs.jmedchem.1c00758","article-title":"Discovery of potent and broad-spectrum pyrazolopyridine-containing antivirals against enteroviruses D68, A71, and coxsackievirus B3 by targeting the viral 2C protein","volume":"64","author":"Hu","year":"2021","journal-title":"J Med Chem"},{"key":"10.1016\/j.jare.2023.03.007_b0475","doi-asserted-by":"crossref","first-page":"636","DOI":"10.3389\/fmicb.2019.00636","article-title":"Elucidating the host interactome of EV-A71 2C reveals viral dependency factors","volume":"10","author":"Li","year":"2019","journal-title":"Front Microbiol"},{"issue":"8","key":"10.1016\/j.jare.2023.03.007_b0480","doi-asserted-by":"crossref","first-page":"e1007962","DOI":"10.1371\/journal.ppat.1007962","article-title":"Convergent evolution in the mechanisms of ACBD3 recruitment to picornavirus replication sites","volume":"15","author":"Horova","year":"2019","journal-title":"PLoS Pathog"},{"issue":"5","key":"10.1016\/j.jare.2023.03.007_b0485","doi-asserted-by":"crossref","first-page":"2654","DOI":"10.1128\/AAC.05108-14","article-title":"Discovery of itraconazole with broad-spectrum in vitro antienterovirus activity that targets nonstructural protein 3A","volume":"59","author":"Gao","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jare.2023.03.007_b0490","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.antiviral.2017.04.008","article-title":"Antiviral screen identifies EV71 inhibitors and reveals camptothecin-target, DNA topoisomerase 1 as a novel EV71 host factor","volume":"143","author":"Wu","year":"2017","journal-title":"Antiviral Res"},{"issue":"22","key":"10.1016\/j.jare.2023.03.007_b0495","doi-asserted-by":"crossref","first-page":"9633","DOI":"10.1093\/nar\/gkr682","article-title":"Far upstream element binding protein 1 binds the internal ribosomal entry site of enterovirus 71 and enhances viral translation and viral growth","volume":"39","author":"Huang","year":"2011","journal-title":"Nucleic Acids Res"},{"issue":"12","key":"10.1016\/j.jare.2023.03.007_b0500","doi-asserted-by":"crossref","first-page":"6106","DOI":"10.1128\/JVI.02476-08","article-title":"hnRNP A1 interacts with the 5' untranslated regions of enterovirus 71 and Sindbis virus RNA and is required for viral replication","volume":"83","author":"Lin","year":"2009","journal-title":"J Virol"},{"issue":"19","key":"10.1016\/j.jare.2023.03.007_b0505","doi-asserted-by":"crossref","first-page":"2841","DOI":"10.1016\/j.jmb.2017.06.007","article-title":"HnRNP A1 alters the structure of a conserved enterovirus IRES domain to stimulate viral translation","volume":"429","author":"Tolbert","year":"2017","journal-title":"J Mol Biol"},{"issue":"5","key":"10.1016\/j.jare.2023.03.007_b0510","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1099\/jgv.0.000431","article-title":"Idarubicin is a broad-spectrum enterovirus replication inhibitor that selectively targets the virus internal ribosomal entry site","volume":"97","author":"Hou","year":"2016","journal-title":"J Gen Virol"},{"issue":"10","key":"10.1016\/j.jare.2023.03.007_b0515","doi-asserted-by":"crossref","first-page":"e110429","DOI":"10.1371\/journal.pone.0110429","article-title":"Apigenin inhibits enterovirus-71 infection by disrupting viral RNA association with trans-acting factors","volume":"9","author":"Zhang","year":"2014","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.jare.2023.03.007_b0520","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1248\/bpb.b14-00357","article-title":"Antiviral activity of Paulownia tomentosa against enterovirus 71 of hand, foot, and mouth disease","volume":"38","author":"Ji","year":"2015","journal-title":"Biol Pharm Bull"},{"issue":"1","key":"10.1016\/j.jare.2023.03.007_b0525","doi-asserted-by":"crossref","first-page":"4775","DOI":"10.1038\/s41467-020-18594-3","article-title":"IRES-targeting small molecule inhibits enterovirus 71 replication via allosteric stabilization of a ternary complex","volume":"11","author":"Davila-Calderon","year":"2020","journal-title":"Nat Commun"},{"issue":"2","key":"10.1016\/j.jare.2023.03.007_b0530","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.foodchem.2011.03.022","article-title":"Kaempferol inhibits enterovirus 71 replication and internal ribosome entry site (IRES) activity through FUBP and HNRP proteins","volume":"128","author":"Tsai","year":"2011","journal-title":"Food Chem"},{"issue":"1","key":"10.1016\/j.jare.2023.03.007_b0535","doi-asserted-by":"crossref","first-page":"e52954","DOI":"10.1371\/journal.pone.0052954","article-title":"Quinacrine impairs enterovirus 71 RNA replication by preventing binding of polypyrimidine-tract binding protein with internal ribosome entry sites","volume":"8","author":"Wang","year":"2013","journal-title":"PLoS One"},{"issue":"11","key":"10.1016\/j.jare.2023.03.007_b0540","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1111\/j.1745-7254.2008.00876.x","article-title":"Amantadine as a regulator of internal ribosome entry site","volume":"29","author":"Chen","year":"2008","journal-title":"Acta Pharmacol Sin"},{"key":"10.1016\/j.jare.2023.03.007_b0545","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.antiviral.2014.04.004","article-title":"Inhibition of enterovirus 71 infection by antisense octaguanidinium dendrimer-conjugated morpholino oligomers","volume":"107","author":"Tan","year":"2014","journal-title":"Antiviral Res"},{"issue":"1","key":"10.1016\/j.jare.2023.03.007_b0550","doi-asserted-by":"crossref","first-page":"e0191617","DOI":"10.1371\/journal.pone.0191617","article-title":"Inhibition of EV71 by curcumin in intestinal epithelial cells","volume":"13","author":"Huang","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.jare.2023.03.007_b0555","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.antiviral.2018.02.015","article-title":"Honeysuckle-encoded microRNA2911 inhibits enterovirus 71 replication via targeting VP1 gene","volume":"152","author":"Li","year":"2018","journal-title":"Antiviral Res"},{"issue":"21","key":"10.1016\/j.jare.2023.03.007_b0560","doi-asserted-by":"crossref","first-page":"12495","DOI":"10.1021\/acsomega.0c01382","article-title":"Inhibition of enterovirus 71 by selenium nanoparticles loaded with siRNA through bax signaling pathways","volume":"5","author":"Lin","year":"2020","journal-title":"ACS Omega"},{"issue":"9","key":"10.1016\/j.jare.2023.03.007_b0565","doi-asserted-by":"crossref","first-page":"1968","DOI":"10.1007\/s00284-020-02082-4","article-title":"The function and mechanism of enterovirus 71 (EV71) 3C protease","volume":"77","author":"Wen","year":"2020","journal-title":"Curr Microbiol"},{"key":"10.1016\/j.jare.2023.03.007_b0570","first-page":"26","article-title":"A novel enterovirus 71 (EV71) virulence determinant: the 69th residue of 3C protease modulates pathogenicity","volume":"7","author":"Li","year":"2017","journal-title":"Front Cell Infect Microbiol"},{"issue":"2","key":"10.1016\/j.jare.2023.03.007_b0575","doi-asserted-by":"crossref","first-page":"201","DOI":"10.3748\/wjg.v16.i2.201","article-title":"Rupintrivir is a promising candidate for treating severe cases of Enterovirus-71 infection","volume":"16","author":"Zhang","year":"2010","journal-title":"World J Gastroenterol"},{"issue":"3","key":"10.1016\/j.jare.2023.03.007_b0580","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.antiviral.2012.12.029","article-title":"Rupintrivir is a promising candidate for treating severe cases of enterovirus-71 infection: evaluation of antiviral efficacy in a murine infection model","volume":"97","author":"Zhang","year":"2013","journal-title":"Antiviral Res"},{"issue":"5","key":"10.1016\/j.jare.2023.03.007_b0585","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1016\/j.jmii.2016.12.006","article-title":"Association of EV71 3C polymorphisms with clinical severity","volume":"51","author":"Ma","year":"2018","journal-title":"J Microbiol Immunol Infect"},{"issue":"19","key":"10.1016\/j.jare.2023.03.007_b0590","doi-asserted-by":"crossref","first-page":"10319","DOI":"10.1128\/JVI.00787-11","article-title":"Enterovirus 71 and coxsackievirus A16 3C proteases: binding to rupintrivir and their substrates and anti-hand, foot, and mouth disease virus drug design","volume":"85","author":"Lu","year":"2011","journal-title":"J Virol"},{"issue":"12","key":"10.1016\/j.jare.2023.03.007_b0595","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1093\/infdis\/jir174","article-title":"Synergistic inhibition of enterovirus 71 replication by interferon and rupintrivir","volume":"203","author":"Hung","year":"2011","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jare.2023.03.007_b0600","article-title":"Design, synthesis, and biological evaluation of peptidomimetic aldehydes as broad-spectrum inhibitors against enterovirus and SARS-CoV-2","author":"Dai","year":"2021","journal-title":"J Med Chem"},{"issue":"8","key":"10.1016\/j.jare.2023.03.007_b0605","doi-asserted-by":"crossref","first-page":"4339","DOI":"10.1128\/JVI.01123-12","article-title":"3C protease of enterovirus 68: structure-based design of Michael acceptor inhibitors and their broad-spectrum antiviral effects against picornaviruses","volume":"87","author":"Tan","year":"2013","journal-title":"J Virol"},{"issue":"9","key":"10.1016\/j.jare.2023.03.007_b0610","doi-asserted-by":"crossref","first-page":"5814","DOI":"10.1128\/AAC.00534-15","article-title":"The enterovirus 3C protease inhibitor SG85 efficiently blocks rhinovirus replication and is not cross-resistant with rupintrivir","volume":"59","author":"Lacroix","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jare.2023.03.007_b0615","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.bpc.2016.09.005","article-title":"Susceptibility of inhibitors against 3C protease of coxsackievirus A16 and enterovirus A71 causing hand, foot and mouth disease: a molecular dynamics study","volume":"219","author":"Jetsadawisut","year":"2016","journal-title":"Biophys Chem"},{"issue":"14","key":"10.1016\/j.jare.2023.03.007_b0620","doi-asserted-by":"crossref","first-page":"3346","DOI":"10.1016\/j.bmcl.2016.05.036","article-title":"Design, synthesis, and biological evaluation of anti-EV71 agents","volume":"26","author":"Li","year":"2016","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.jare.2023.03.007_b0625","doi-asserted-by":"crossref","DOI":"10.1016\/j.antiviral.2021.105102","article-title":"Reversible covalent inhibitors suppress enterovirus 71 infection by targeting the 3C protease","volume":"192","author":"Liu","year":"2021","journal-title":"Antiviral Res"},{"issue":"7","key":"10.1016\/j.jare.2023.03.007_b0630","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00298-17","article-title":"Structure of the enterovirus 71 3C protease in complex with NK-1.8k and indications for the development of antienterovirus protease inhibitor","volume":"61","author":"Wang","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"issue":"5","key":"10.1016\/j.jare.2023.03.007_b0635","doi-asserted-by":"crossref","first-page":"2636","DOI":"10.1128\/AAC.00049-15","article-title":"Peptidyl aldehyde NK-1.8k suppresses enterovirus 71 and enterovirus 68 infection by targeting protease 3C","volume":"59","author":"Wang","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"issue":"2","key":"10.1016\/j.jare.2023.03.007_b0640","doi-asserted-by":"crossref","first-page":"332","DOI":"10.3109\/14756366.2015.1018245","article-title":"Peptidomimetic ethyl propenoate covalent inhibitors of the enterovirus 71 3C protease: a P2\u2013P4 study","volume":"31","author":"Ang","year":"2016","journal-title":"J Enzyme Inhib Med Chem"},{"key":"10.1016\/j.jare.2023.03.007_b0645","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/j.ejmech.2016.08.064","article-title":"Structure-activity relationship study of peptidomimetic aldehydes as enterovirus 71 3C protease inhibitors","volume":"124","author":"Zhai","year":"2016","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.jare.2023.03.007_b0650","doi-asserted-by":"crossref","first-page":"33663","DOI":"10.1038\/srep33663","article-title":"Antiviral activities of peptide-based covalent inhibitors of the Enterovirus 71 3C protease","volume":"6","author":"Tan","year":"2016","journal-title":"Sci Rep"},{"issue":"23","key":"10.1016\/j.jare.2023.03.007_b0655","doi-asserted-by":"crossref","first-page":"9414","DOI":"10.1021\/acs.jmedchem.5b01013","article-title":"Cyanohydrin as an anchoring group for potent and selective inhibitors of enterovirus 71 3C protease","volume":"58","author":"Zhai","year":"2015","journal-title":"J Med Chem"},{"issue":"22","key":"10.1016\/j.jare.2023.03.007_b0660","doi-asserted-by":"crossref","first-page":"10333","DOI":"10.1021\/acs.jmedchem.8b01335","article-title":"4-Iminooxazolidin-2-one as a bioisostere of the cyanohydrin moiety: inhibitors of enterovirus 71 3C protease","volume":"61","author":"Ma","year":"2018","journal-title":"J Med Chem"},{"issue":"3","key":"10.1016\/j.jare.2023.03.007_b0665","doi-asserted-by":"crossref","first-page":"e0102521","DOI":"10.1128\/Spectrum.01025-21","article-title":"4-Iminooxazolidin-2-one as a bioisostere of cyanohydrin suppresses EV71 proliferation by targeting 3C(pro)","volume":"9","author":"Xu","year":"2021","journal-title":"Microbiol Spectr"},{"key":"10.1016\/j.jare.2023.03.007_b0670","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1016\/j.ejmech.2016.10.019","article-title":"Identification and biochemical characterization of DC07090 as a novel potent small molecule inhibitor against human enterovirus 71 3C protease by structure-based virtual screening","volume":"124","author":"Ma","year":"2016","journal-title":"Eur J Med Chem"},{"issue":"2","key":"10.1016\/j.jare.2023.03.007_b0675","doi-asserted-by":"crossref","first-page":"e0148693","DOI":"10.1371\/journal.pone.0148693","article-title":"Luteoloside acts as 3C protease inhibitor of enterovirus 71 in vitro","volume":"11","author":"Cao","year":"2016","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.jare.2023.03.007_b0680","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.antiviral.2012.12.005","article-title":"Antiviral drug discovery for the treatment of enterovirus 71 infections","volume":"97","author":"Shang","year":"2013","journal-title":"Antiviral Res"},{"issue":"3","key":"10.1016\/j.jare.2023.03.007_b0685","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.antiviral.2010.12.007","article-title":"Picornavirus non-structural proteins as targets for new anti-virals with broad activity","volume":"89","author":"Norder","year":"2011","journal-title":"Antiviral Res"},{"issue":"1","key":"10.1016\/j.jare.2023.03.007_b0690","doi-asserted-by":"crossref","first-page":"e28400","DOI":"10.1002\/jmv.28400","article-title":"Phosphorylation of enteroviral 2A(pro) at Ser\/Thr125 benefits its proteolytic activity and viral pathogenesis","volume":"95","author":"Wang","year":"2023","journal-title":"J Med Virol"},{"issue":"1","key":"10.1016\/j.jare.2023.03.007_b0695","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.celrep.2015.05.047","article-title":"Reciprocal regulation between enterovirus 71 and the NLRP3 inflammasome","volume":"12","author":"Wang","year":"2015","journal-title":"Cell Rep"},{"issue":"3","key":"10.1016\/j.jare.2023.03.007_b0700","doi-asserted-by":"crossref","first-page":"e1003231","DOI":"10.1371\/journal.ppat.1003231","article-title":"Enterovirus 71 protease 2Apro targets MAVS to inhibit anti-viral type I interferon responses","volume":"9","author":"Wang","year":"2013","journal-title":"PLoS Pathog"},{"issue":"13","key":"10.1016\/j.jare.2023.03.007_b0705","doi-asserted-by":"crossref","first-page":"7348","DOI":"10.1128\/JVI.03541-12","article-title":"Conformational plasticity of the 2A proteinase from enterovirus 71","volume":"87","author":"Cai","year":"2013","journal-title":"J Virol"},{"issue":"9","key":"10.1016\/j.jare.2023.03.007_b0710","doi-asserted-by":"crossref","first-page":"e76007","DOI":"10.1371\/journal.pone.0076007","article-title":"Chlorogenic acid inhibits the replication and viability of enterovirus 71 in vitro","volume":"8","author":"Li","year":"2013","journal-title":"PLoS One"},{"issue":"12","key":"10.1016\/j.jare.2023.03.007_b0715","doi-asserted-by":"crossref","first-page":"2865","DOI":"10.1093\/jac\/dks304","article-title":"Blocking human enterovirus 71 replication by targeting viral 2A protease","volume":"67","author":"Falah","year":"2012","journal-title":"J Antimicrob Chemother"},{"issue":"1","key":"10.1016\/j.jare.2023.03.007_b0720","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1038\/s41598-017-01110-x","article-title":"Antiviral activities of Schizonepeta tenuifolia Briq. against enterovirus 71 in vitro and in vivo","volume":"7","author":"Chen","year":"2017","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.jare.2023.03.007_b0725","doi-asserted-by":"crossref","first-page":"12264","DOI":"10.1038\/s41598-017-12388-2","article-title":"Anti-enterovirus 71 activities of Melissa officinalis extract and its biologically active constituent rosmarinic acid","volume":"7","author":"Chen","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.jare.2023.03.007_b0730","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.antiviral.2018.10.012","article-title":"Substituted 3-benzylcoumarins 13 and 14 suppress enterovirus A71 replication by impairing viral 2A(pro) dependent IRES-driven translation","volume":"160","author":"Zhang","year":"2018","journal-title":"Antiviral Res"},{"issue":"7","key":"10.1016\/j.jare.2023.03.007_b0735","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.02221-18","article-title":"Validating enterovirus D68\u20132A(pro) as an antiviral drug target and the discovery of telaprevir as a potent D68\u20132A(pro) inhibitor","volume":"93","author":"Musharrafieh","year":"2019","journal-title":"J Virol"},{"issue":"2","key":"10.1016\/j.jare.2023.03.007_b0740","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.02016-16","article-title":"Enterovirus 71 3C promotes apoptosis through cleavage of PinX1, a telomere binding protein","volume":"91","author":"Li","year":"2017","journal-title":"J Virol"},{"key":"10.1016\/j.jare.2023.03.007_b0745","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.antiviral.2017.07.001","article-title":"Antiviral effects of Retro-2(cycl) and Retro-2.1 against Enterovirus 71 in vitro and in vivo","volume":"144","author":"Dai","year":"2017","journal-title":"Antiviral Res"},{"issue":"3","key":"10.1016\/j.jare.2023.03.007_b0750","first-page":"176","article-title":"[Autophagy inhibitor 3-MA decreases the production and release of infectious enterovirus 71 particles]","volume":"25","author":"Zhang","year":"2011","journal-title":"Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi"},{"key":"10.1016\/j.jare.2023.03.007_b0755","first-page":"2249","article-title":"Immunopathogenesis and virus-host interactions of enterovirus 71 in patients with hand","volume":"8","author":"Cox","year":"2017","journal-title":"Foot Mouth Disease Front Microbiol"},{"issue":"1","key":"10.1016\/j.jare.2023.03.007_b0760","doi-asserted-by":"crossref","first-page":"e2016","DOI":"10.1002\/rmv.2016","article-title":"An update on enterovirus 71 infection and interferon type I response","volume":"29","author":"Rasti","year":"2019","journal-title":"Rev Med Virol"},{"issue":"9","key":"10.1016\/j.jare.2023.03.007_b0765","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1002\/2211-5463.12490","article-title":"MicroR-9-5p suppresses EV71 replication through targeting NF\u03baB of the RIG-I-mediated innate immune response","volume":"8","author":"Li","year":"2018","journal-title":"FEBS Open Bio"},{"key":"10.1016\/j.jare.2023.03.007_b0770","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.antiviral.2018.02.002","article-title":"GS-9620 inhibits enterovirus 71 replication mainly through the NF-\u03baB and PI3K-AKT signaling pathways","volume":"153","author":"Zhang","year":"2018","journal-title":"Antiviral Res"},{"issue":"2","key":"10.1016\/j.jare.2023.03.007_b0775","doi-asserted-by":"crossref","first-page":"e0116879","DOI":"10.1371\/journal.pone.0116879","article-title":"Resveratrol inhibits enterovirus 71 replication and pro-inflammatory cytokine secretion in rhabdosarcoma cells through blocking IKKs\/NF-\u03baB signaling pathway","volume":"10","author":"Zhang","year":"2015","journal-title":"PLoS One"},{"issue":"10","key":"10.1016\/j.jare.2023.03.007_b0780","doi-asserted-by":"crossref","first-page":"e6586","DOI":"10.1590\/1414-431x20176586","article-title":"Antiviral activity of shikonin ester derivative PMM-034 against enterovirus 71 in vitro","volume":"50","author":"Zhang","year":"2017","journal-title":"Braz J Med Biol Res"},{"key":"10.1016\/j.jare.2023.03.007_b0785","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.antiviral.2015.04.009","article-title":"Saururus chinensis (Lour.) Baill blocks enterovirus 71 infection by hijacking MEK1-ERK signaling pathway","volume":"119","author":"Wang","year":"2015","journal-title":"Antiviral Res"},{"key":"10.1016\/j.jare.2023.03.007_b0790","doi-asserted-by":"crossref","DOI":"10.1016\/j.antiviral.2021.105021","article-title":"Cathelicidin antimicrobial peptides suppress EV71 infection via regulating antiviral response and inhibiting viral binding","volume":"187","author":"Yu","year":"2021","journal-title":"Antiviral Res"},{"issue":"16","key":"10.1016\/j.jare.2023.03.007_b0795","doi-asserted-by":"crossref","first-page":"3472","DOI":"10.1016\/j.bmc.2016.05.055","article-title":"Discovery of 3-benzyl-1,3-benzoxazine-2,4-dione analogues as allosteric mitogen-activated kinase kinase (MEK) inhibitors and anti-enterovirus 71 (EV71) agents","volume":"24","author":"Sun","year":"2016","journal-title":"Bioorg Med Chem"},{"issue":"Pt 12","key":"10.1016\/j.jare.2023.03.007_b0800","doi-asserted-by":"crossref","first-page":"3263","DOI":"10.1099\/vir.0.81195-0","article-title":"Type I interferons protect mice against enterovirus 71 infection","volume":"86","author":"Liu","year":"2005","journal-title":"J Gen Virol"},{"issue":"2","key":"10.1016\/j.jare.2023.03.007_b0805","doi-asserted-by":"crossref","first-page":"e0148907","DOI":"10.1371\/journal.pone.0148907","article-title":"Clinical efficacy of therapy with recombinant human interferon \u03b11b in hand, foot, and mouth disease with enterovirus 71 infection","volume":"11","author":"Huang","year":"2016","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.jare.2023.03.007_b0810","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.ijantimicag.2008.04.018","article-title":"Aloe-emodin is an interferon-inducing agent with antiviral activity against Japanese encephalitis virus and enterovirus 71","volume":"32","author":"Lin","year":"2008","journal-title":"Int J Antimicrob Agents"},{"issue":"9","key":"10.1016\/j.jare.2023.03.007_b0815","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1017\/S0007114513004133","article-title":"Effect of all-trans-retinoic acid on enterovirus 71 infection in vitro","volume":"111","author":"Chen","year":"2014","journal-title":"Br J Nutr"},{"key":"10.1016\/j.jare.2023.03.007_b0820","article-title":"Anemoside B4 inhibits enterovirus 71 propagation in mice through upregulating 14-3-3 expression and type I interferon responses","author":"Kang","year":"2021","journal-title":"Acta Pharmacol Sin"},{"key":"10.1016\/j.jare.2023.03.007_b0825","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2020.113401","article-title":"Ginsenoside Rb1 is an immune-stimulatory agent with antiviral activity against enterovirus 71","volume":"266","author":"Kang","year":"2021","journal-title":"J Ethnopharmacol"},{"key":"10.1016\/j.jare.2023.03.007_b0830","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.762285","article-title":"Isolation and identification of andrographis paniculata (Chuanxinlian) and its biologically active constituents inhibited enterovirus 71-induced cell apoptosis","volume":"12","author":"Chao","year":"2021","journal-title":"Front Pharmacol"},{"issue":"1","key":"10.1016\/j.jare.2023.03.007_b0835","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1186\/s12929-019-0585-y","article-title":"Hypoxia and therapeutic treatment of EV-A71 with an immune modulator TLR7 agonist in a new immunocompetent mouse model","volume":"26","author":"Liou","year":"2019","journal-title":"J Biomed Sci"},{"issue":"2","key":"10.1016\/j.jare.2023.03.007_b0840","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1007\/s13238-012-2081-y","article-title":"MicroRNA-548 down-regulates host antiviral response via direct targeting of IFN-\u03bb1","volume":"4","author":"Li","year":"2013","journal-title":"Protein Cell"},{"key":"10.1016\/j.jare.2023.03.007_b0845","doi-asserted-by":"crossref","first-page":"3344","DOI":"10.1038\/ncomms4344","article-title":"Inhibition of miR-146a prevents enterovirus-induced death by restoring the production of type I interferon","volume":"5","author":"Ho","year":"2014","journal-title":"Nat Commun"},{"issue":"6","key":"10.1016\/j.jare.2023.03.007_b0850","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1586\/eri.09.45","article-title":"Enterovirus 71: epidemiology, pathogenesis and management","volume":"7","author":"Wang","year":"2009","journal-title":"Expert Rev Anti Infect Ther"},{"issue":"1","key":"10.1016\/j.jare.2023.03.007_b0855","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.jcv.2006.05.009","article-title":"Modulation of cytokine production by intravenous immunoglobulin in patients with enterovirus 71-associated brainstem encephalitis","volume":"37","author":"Wang","year":"2006","journal-title":"J Clin Virol"},{"issue":"9","key":"10.1016\/j.jare.2023.03.007_b0860","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.3201\/eid2209.151579","article-title":"Prediction of protection against asian enterovirus 71 outbreak strains by cross-neutralizing capacity of serum from dutch donors","volume":"22","author":"van der Sanden","year":"2016","journal-title":"Netherlands Emerg Infect Dis"},{"issue":"3","key":"10.1016\/j.jare.2023.03.007_b0865","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.biologicals.2013.02.002","article-title":"Neutralization of five subgenotypes of Enterovirus 71 by Taiwanese human plasma and Taiwanese plasma derived intravenous immunoglobulin","volume":"41","author":"Wu","year":"2013","journal-title":"Biologicals"},{"issue":"11","key":"10.1016\/j.jare.2023.03.007_b0870","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.2174\/138161206776361129","article-title":"Current status of anti-picornavirus therapies","volume":"12","author":"Barnard","year":"2006","journal-title":"Curr Pharm Des"},{"issue":"5","key":"10.1016\/j.jare.2023.03.007_b0875","doi-asserted-by":"crossref","DOI":"10.3390\/pathogens10050625","article-title":"Response of severe EV71-infected patients to hyperimmune plasma treatment: a pilot study","volume":"10","author":"Techasaensiri","year":"2021","journal-title":"Pathogens"},{"issue":"7","key":"10.1016\/j.jare.2023.03.007_b0880","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1038\/cdd.2009.33","article-title":"Life and death partners: apoptosis, autophagy and the cross-talk between them","volume":"16","author":"Eisenberg-Lerner","year":"2009","journal-title":"Cell Death Differ"},{"issue":"2","key":"10.1016\/j.jare.2023.03.007_b0885","doi-asserted-by":"crossref","first-page":"e56966","DOI":"10.1371\/journal.pone.0056966","article-title":"The interplays between autophagy and apoptosis induced by enterovirus 71","volume":"8","author":"Xi","year":"2013","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.jare.2023.03.007_b0890","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1186\/s12929-014-0080-4","article-title":"Enterovirus 71-induced autophagy increases viral replication and pathogenesis in a suckling mouse model","volume":"21","author":"Lee","year":"2014","journal-title":"J Biomed Sci"},{"key":"10.1016\/j.jare.2023.03.007_b0895","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2021.119188","article-title":"Enterovirus 71 induces autophagy in mice via mTOR inhibition and ERK pathway activation","volume":"271","author":"Wang","year":"2021","journal-title":"Life Sci"},{"issue":"7","key":"10.1016\/j.jare.2023.03.007_b0900","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1002\/jmv.21502","article-title":"Enterovirus 71-induced autophagy detected in vitro and in vivo promotes viral replication","volume":"81","author":"Huang","year":"2009","journal-title":"J Med Virol"},{"key":"10.1016\/j.jare.2023.03.007_b0905","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.ejmech.2019.04.048","article-title":"Design, synthesis and pharmacological evaluation of a novel mTOR-targeted anti-EV71 agent","volume":"175","author":"Hao","year":"2019","journal-title":"Eur J Med Chem"},{"issue":"3","key":"10.1016\/j.jare.2023.03.007_b0910","doi-asserted-by":"crossref","DOI":"10.1042\/BSR20140141","article-title":"MAPK\/JNK signalling: a potential autophagy regulation pathway","volume":"35","author":"Zhou","year":"2015","journal-title":"Biosci Rep"},{"issue":"1","key":"10.1016\/j.jare.2023.03.007_b0915","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s12985-016-0674-4","article-title":"Berberine inhibits enterovirus 71 replication by downregulating the MEK\/ERK signaling pathway and autophagy","volume":"14","author":"Wang","year":"2017","journal-title":"Virol J"},{"issue":"8","key":"10.1016\/j.jare.2023.03.007_b0920","doi-asserted-by":"crossref","DOI":"10.3390\/molecules23082084","article-title":"Synthesis and evolution of berberine derivatives as a new class of antiviral agents against enterovirus 71 through the MEK\/ERK pathway and autophagy","volume":"23","author":"Wang","year":"2018","journal-title":"Molecules"},{"key":"10.1016\/j.jare.2023.03.007_b0925","doi-asserted-by":"crossref","first-page":"277","DOI":"10.3389\/fcimb.2019.00277","article-title":"Lycorine derivative LY-55 inhibits EV71 and CVA16 replication through downregulating autophagy","volume":"9","author":"Wang","year":"2019","journal-title":"Front Cell Infect Microbiol"},{"issue":"21","key":"10.1016\/j.jare.2023.03.007_b0930","doi-asserted-by":"crossref","first-page":"11514","DOI":"10.1093\/nar\/gky840","article-title":"Enterovirus 71 antagonizes the inhibition of the host intrinsic antiviral factor A3G","volume":"46","author":"Li","year":"2018","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.jare.2023.03.007_b0935","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.antiviral.2019.03.005","article-title":"APOBEC3G is a restriction factor of EV71 and mediator of IMB-Z antiviral activity","volume":"165","author":"Wang","year":"2019","journal-title":"Antiviral Res"},{"issue":"24","key":"10.1016\/j.jare.2023.03.007_b0940","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.01092-19","article-title":"Activity-based protein profiling identifies ATG4B as a key host factor for enterovirus 71 proliferation","volume":"93","author":"Sun","year":"2019","journal-title":"J Virol"},{"issue":"6","key":"10.1016\/j.jare.2023.03.007_b0945","doi-asserted-by":"crossref","DOI":"10.1093\/femspd\/ftab036","article-title":"Knockdown of METTL3 inhibits enterovirus 71-induced apoptosis of mouse Schwann cell through regulation of autophagy","volume":"79","author":"Xiao","year":"2021","journal-title":"Pathog Dis"},{"key":"10.1016\/j.jare.2023.03.007_b0950","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.antiviral.2015.09.016","article-title":"Enterovirus 71 induces autophagy by regulating has-miR-30a expression to promote viral replication","volume":"124","author":"Fu","year":"2015","journal-title":"Antiviral Res"},{"issue":"5","key":"10.1016\/j.jare.2023.03.007_b0955","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.cytogfr.2014.08.002","article-title":"Death waits for no man\u2013does it wait for a virus? How enteroviruses induce and control cell death","volume":"25","author":"Harris","year":"2014","journal-title":"Cytokine Growth Factor Rev"},{"key":"10.1016\/j.jare.2023.03.007_b0960","doi-asserted-by":"crossref","first-page":"817","DOI":"10.3389\/fmicb.2018.00817","article-title":"Caspase-3 inhibition attenuates the cytopathic effects of EV71 infection","volume":"9","author":"Song","year":"2018","journal-title":"Front Microbiol"},{"key":"10.1016\/j.jare.2023.03.007_b0965","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/j.carbpol.2015.12.005","article-title":"Structural characterization and antiviral activity of a novel heteropolysaccharide isolated from Grifola frondosa against enterovirus 71","volume":"144","author":"Zhao","year":"2016","journal-title":"Carbohydr Polym"},{"issue":"1","key":"10.1016\/j.jare.2023.03.007_b0970","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1142\/S0192415X09006734","article-title":"Anti-enterovirus 71 activity screening of chinese herbs with anti-infection and inflammation activities","volume":"37","author":"Lin","year":"2009","journal-title":"Am J Chin Med"},{"key":"10.1016\/j.jare.2023.03.007_b0975","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.jep.2016.03.034","article-title":"Gan-Lu-Siao-Du-yin, a prescription of traditional Chinese medicine, inhibited enterovirus 71 replication, translation, and virus-induced cell apoptosis","volume":"185","author":"Hsieh","year":"2016","journal-title":"J Ethnopharmacol"},{"issue":"1","key":"10.1016\/j.jare.2023.03.007_b0980","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1111\/j.1582-4934.2005.tb00337.x","article-title":"The activation of Akt\/PKB signaling pathway and cell survival","volume":"9","author":"Song","year":"2005","journal-title":"J Cell Mol Med"},{"issue":"1","key":"10.1016\/j.jare.2023.03.007_b0985","doi-asserted-by":"crossref","first-page":"38","DOI":"10.4014\/jmb.1907.07079","article-title":"Salvianolic acid B inhibits hand-foot-mouth disease enterovirus 71 replication through enhancement of AKT signaling pathway","volume":"30","author":"Kim","year":"2020","journal-title":"J Microbiol Biotechnol"},{"key":"10.1016\/j.jare.2023.03.007_b0990","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.carbpol.2018.07.067","article-title":"Antiviral activity against enterovirus 71 of sulfated rhamnan isolated from the green alga Monostroma latissimum","volume":"200","author":"Wang","year":"2018","journal-title":"Carbohydr Polym"},{"key":"10.1016\/j.jare.2023.03.007_b0995","doi-asserted-by":"crossref","DOI":"10.1016\/j.carbpol.2019.115280","article-title":"A sulfated glucuronorhamnan from the green seaweed Monostroma nitidum: characteristics of its structure and antiviral activity","volume":"227","author":"Wang","year":"2020","journal-title":"Carbohydr Polym"},{"key":"10.1016\/j.jare.2023.03.007_b1000","doi-asserted-by":"crossref","DOI":"10.1007\/s00705-021-05229-1","article-title":"Inhibition of enterovirus 71 infection by polysaccharides extracted from Picochlorum sp. 122 via the AKT and ATM\/ATR signaling pathways","author":"Guo","year":"2021","journal-title":"Arch Virol"},{"issue":"2","key":"10.1016\/j.jare.2023.03.007_b1005","first-page":"737","article-title":"Resveratrol-loaded nanoparticles inhibit enterovirus 71 replication through the oxidative stress-mediated ERS\/autophagy pathway","volume":"44","author":"Du","year":"2019","journal-title":"Int J Mol Med"},{"issue":"1","key":"10.1016\/j.jare.2023.03.007_b1010","doi-asserted-by":"crossref","first-page":"3485","DOI":"10.1080\/21691401.2019.1640716","article-title":"Functionalized selenium nanoparticles enhance the anti-EV71 activity of oseltamivir in human astrocytoma cell model","volume":"47","author":"Zhong","year":"2019","journal-title":"Artif Cells Nanomed Biotechnol"},{"issue":"12","key":"10.1016\/j.jare.2023.03.007_b1015","doi-asserted-by":"crossref","first-page":"3316","DOI":"10.1002\/jcp.22677","article-title":"Enterovirus 71 induces integrin \u03b21\/EGFR-Rac1-dependent oxidative stress in SK-N-SH cells: role of HO-1\/CO in viral replication","volume":"226","author":"Tung","year":"2011","journal-title":"J Cell Physiol"},{"issue":"1","key":"10.1016\/j.jare.2023.03.007_b1020","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1080\/21505594.2020.1766790","article-title":"Enterovirus 71 induces neural cell apoptosis and autophagy through promoting ACOX1 downregulation and ROS generation","volume":"11","author":"You","year":"2020","journal-title":"Virulence"},{"key":"10.1016\/j.jare.2023.03.007_b1025","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.antiviral.2014.06.004","article-title":"Apigenin inhibits enterovirus 71 replication through suppressing viral IRES activity and modulating cellular JNK pathway","volume":"109","author":"Lv","year":"2014","journal-title":"Antiviral Res"},{"issue":"14","key":"10.1016\/j.jare.2023.03.007_b1030","doi-asserted-by":"crossref","first-page":"6140","DOI":"10.1021\/jf901128u","article-title":"Antiviral effect of epigallocatechin gallate on enterovirus 71","volume":"57","author":"Ho","year":"2009","journal-title":"J Agric Food Chem"},{"issue":"1","key":"10.1016\/j.jare.2023.03.007_b1035","doi-asserted-by":"crossref","first-page":"16278","DOI":"10.1038\/s41598-017-16446-7","article-title":"Isochlorogenic acid C prevents enterovirus 71 infection via modulating redox homeostasis of glutathione","volume":"7","author":"Cao","year":"2017","journal-title":"Sci Rep"},{"issue":"10","key":"10.1016\/j.jare.2023.03.007_b1040","doi-asserted-by":"crossref","first-page":"e1004422","DOI":"10.1371\/journal.ppat.1004422","article-title":"Cyclophilin A associates with enterovirus-71 virus capsid and plays an essential role in viral infection as an uncoating regulator","volume":"10","author":"Qing","year":"2014","journal-title":"PLoS Pathog"},{"issue":"24","key":"10.1016\/j.jare.2023.03.007_b1045","doi-asserted-by":"crossref","first-page":"5682","DOI":"10.1016\/j.bmcl.2015.11.002","article-title":"Identification, synthesis and pharmacological evaluation of novel anti-EV71 agents via cyclophilin A inhibition","volume":"25","author":"Yan","year":"2015","journal-title":"Bioorg Med Chem Lett"},{"issue":"9","key":"10.1016\/j.jare.2023.03.007_b1050","doi-asserted-by":"crossref","first-page":"4590","DOI":"10.1021\/es305282g","article-title":"Chlorine dioxide inactivation of enterovirus 71 in water and its impact on genomic targets","volume":"47","author":"Jin","year":"2013","journal-title":"Environ Sci Technol"},{"issue":"3","key":"10.1016\/j.jare.2023.03.007_b1055","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.antiviral.2005.12.007","article-title":"Effects of ozone exposure on inactivation of intra- and extracellular enterovirus 71","volume":"70","author":"Lin","year":"2006","journal-title":"Antiviral Res"},{"issue":"10","key":"10.1016\/j.jare.2023.03.007_b1060","doi-asserted-by":"crossref","first-page":"2176","DOI":"10.1093\/jac\/dkq301","article-title":"Methylene blue-mediated photodynamic inactivation as a novel disinfectant of enterovirus 71","volume":"65","author":"Wong","year":"2010","journal-title":"J Antimicrob Chemother"},{"issue":"9","key":"10.1016\/j.jare.2023.03.007_b1065","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1016\/j.ajic.2011.01.015","article-title":"Inactivation of human enterovirus 71 and coxsackie virus A16 and hand, foot, and mouth disease","volume":"39","author":"Kadurugamuwa","year":"2011","journal-title":"Am J Infect Control"},{"key":"10.1016\/j.jare.2023.03.007_b1070","unstructured":"Xie J, Li D, Xie G, et al.[Inactivation of EV71 by Exposure to Heat and Ultraviolet Light]. Bing Du Xue Bao. 2015;31(5):500\u20136."},{"issue":"4","key":"10.1016\/j.jare.2023.03.007_b1075","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1159\/000334619","article-title":"Clinical features and management outcomes of severe hand, foot and mouth disease","volume":"21","author":"Tian","year":"2012","journal-title":"Med Princ Pract"},{"key":"10.1016\/j.jare.2023.03.007_b1080","doi-asserted-by":"crossref","first-page":"548","DOI":"10.3389\/fneur.2019.00548","article-title":"Excellent response to plasma exchange in three patients with enterovirus-71 neurological disease","volume":"10","author":"Pascual-Go\u00f1i","year":"2019","journal-title":"Front Neurol"},{"issue":"39","key":"10.1016\/j.jare.2023.03.007_b1085","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2104759118","article-title":"Orthogonal genome-wide screens of bat cells identify MTHFD1 as a target of broad antiviral therapy","volume":"118","author":"Anderson","year":"2021","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"41","key":"10.1016\/j.jare.2023.03.007_b1090","doi-asserted-by":"crossref","first-page":"17457","DOI":"10.1039\/C5NR04139B","article-title":"Hydrophobic pocket targeting probes for enteroviruses","volume":"7","author":"Martikainen","year":"2015","journal-title":"Nanoscale"},{"issue":"4","key":"10.1016\/j.jare.2023.03.007_b1095","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1099\/jgv.0.000723","article-title":"Antiviral activity of acid beta-glucosidase 1 on enterovirus 71, a causative agent of hand, foot and mouth disease","volume":"98","author":"Nakata","year":"2017","journal-title":"J Gen Virol"},{"issue":"11","key":"10.1016\/j.jare.2023.03.007_b1100","doi-asserted-by":"crossref","first-page":"e1001174","DOI":"10.1371\/journal.ppat.1001174","article-title":"Tyrosine sulfation of the amino terminus of PSGL-1 is critical for enterovirus 71 infection","volume":"6","author":"Nishimura","year":"2010","journal-title":"PLoS Pathog"},{"issue":"19","key":"10.1016\/j.jare.2023.03.007_b1105","doi-asserted-by":"crossref","first-page":"4206","DOI":"10.1016\/j.bmcl.2005.06.069","article-title":"Synthesis and antipicornavirus activity of (R)- and (S)-1-[5-(4'-chlorobiphenyl-4-yloxy)-3-methylpentyl]-3-pyridin-4-yl-imidazolidin-2-one","volume":"15","author":"Chern","year":"2005","journal-title":"Bioorg Med Chem Lett"},{"issue":"5","key":"10.1016\/j.jare.2023.03.007_b1110","doi-asserted-by":"crossref","first-page":"e1007760","DOI":"10.1371\/journal.ppat.1007760","article-title":"Viral engagement with host receptors blocked by a novel class of tryptophan dendrimers that targets the 5-fold-axis of the enterovirus-A71 capsid","volume":"15","author":"Sun","year":"2019","journal-title":"PLoS Pathog"},{"issue":"8","key":"10.1016\/j.jare.2023.03.007_b1115","doi-asserted-by":"crossref","first-page":"5064","DOI":"10.1128\/AAC.00626-16","article-title":"Optimization of a class of tryptophan dendrimers that inhibit HIV replication leads to a selective, specific, and low-nanomolar inhibitor of clinical isolates of enterovirus A71","volume":"60","author":"Rivero-Buceta","year":"2016","journal-title":"Antimicrob Agents Chemother"},{"issue":"2","key":"10.1016\/j.jare.2023.03.007_b1120","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1142\/S0192415X09006904","article-title":"Water extract of Glycyrrhiza uralensis inhibited enterovirus 71 in a human foreskin fibroblast cell line","volume":"37","author":"Kuo","year":"2009","journal-title":"Am J Chin Med"},{"issue":"1","key":"10.1016\/j.jare.2023.03.007_b1125","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.jep.2008.06.004","article-title":"Sheng-Ma-Ge-Gen-tang inhibited enterovirus 71 infection in human foreskin fibroblast cell line","volume":"119","author":"Chang","year":"2008","journal-title":"J Ethnopharmacol"},{"issue":"3","key":"10.1016\/j.jare.2023.03.007_b1130","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.kjms.2017.11.005","article-title":"Artemisia capillaris inhibited enterovirus 71-induced cell injury by preventing viral internalization","volume":"34","author":"Yen","year":"2018","journal-title":"Kaohsiung J Med Sci"},{"issue":"3","key":"10.1016\/j.jare.2023.03.007_b1135","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.bbrc.2014.05.019","article-title":"Antiviral effects of two Ganoderma lucidum triterpenoids against enterovirus 71 infection","volume":"449","author":"Zhang","year":"2014","journal-title":"Biochem Biophys Res Commun"},{"issue":"Pt 11","key":"10.1016\/j.jare.2023.03.007_b1140","doi-asserted-by":"crossref","first-page":"2734","DOI":"10.1099\/vir.0.023374-0","article-title":"A bifunctional anti-enterovirus compound that inhibits replication and the early stage of enterovirus 71 infection","volume":"91","author":"Arita","year":"2010","journal-title":"J Gen Virol"}],"container-title":["Journal of Advanced Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2090123223000899?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2090123223000899?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T20:57:45Z","timestamp":1761857865000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2090123223000899"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2]]},"references-count":228,"alternative-id":["S2090123223000899"],"URL":"https:\/\/doi.org\/10.1016\/j.jare.2023.03.007","relation":{},"ISSN":["2090-1232"],"issn-type":[{"value":"2090-1232","type":"print"}],"subject":[],"published":{"date-parts":[[2024,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Advances in anti-EV-A71 drug development research","name":"articletitle","label":"Article Title"},{"value":"Journal of Advanced Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jare.2023.03.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier B.V. on behalf of Cairo University.","name":"copyright","label":"Copyright"}]}}